Inspire Medical Systems (INSP) EBIT Margin (2017 - 2026)

Inspire Medical Systems has disclosed EBIT Margin across 10 years of filings, most recently posting 0.55% for Q1 2026.

• EBIT Margin for Q1 2026 came in at 0.55%, up 19.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 5.61% (down 32.0% YoY), and the FY2025 annual result was 5.59%, up 109.0% from the prior year.
• EBIT Margin came in at 0.55% for Q1 2026 at Inspire Medical Systems, down from 17.14% in the prior quarter.
• In the past five years, EBIT Margin ranged from a high of 17.14% in Q4 2025 to a low of 23.14% in Q1 2022.
• The 5-year median for EBIT Margin is 0.74% (2025), against an average of 3.08%.
• Across the five-year window, EBIT Margin soared 1583 bps in 2024 and plunged 413 bps in 2025, its largest moves.
• Inspire Medical Systems' EBIT Margin stood at 0.24% in 2022, then soared by 2088 bps to 4.83% in 2023, then jumped by 175 bps to 13.3% in 2024, then advanced by 29 bps to 17.14% in 2025, then sank by 103 bps to 0.55% in 2026.
• The last three EBIT Margin figures came in at 0.55% (Q1 2026), 17.14% (Q4 2025), and 4.3% (Q3 2025), per Business Quant data.